Starbucks profits dip on continued drag from Covid-19
[NEW YORK] Starbucks reported a drop in quarterly profits Tuesday as it staged a partial recovery from the most severe stretch of Covid-19 restrictions.
The coffee giant continued a gradual recovery from an unprofitable quarter in the middle of 2020, as it returned to comparable sales growth in China and suffered a smaller decline in the United States compared with the year-ago period, but revenues nonetheless lagged analyst estimates.
"Our results demonstrate the continued strength and relevance of our brand," said chief executive Kevin Johnson.
"We remain optimistic about our robust operating outlook for fiscal 2021 as well as our ability to unlock the full potential of Starbucks to create value for our stakeholders."
The company reported fiscal first-quarter profits of US$622.2 million for the quarter ending Dec 27, down 29.8 per cent from the year-ago period on a 4.9 per cent drop in revenues to US$6.7 billion.
US comparable sales fell five per cent, better than the nine per cent slide in the prior quarter. China comparable sales rose five per cent, up from a three per cent decline in the prior quarter.
GET BT IN YOUR INBOX DAILY
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
Starbucks lifted its full-year profit forecast, but projected second-quarter profits below Wall Street analyst expectations, placing more of the expected improvement for later in the year.
Shares fell 1.2 percent to US$103.42 in after-hours trading.
AFP
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Harvard applications drop 5% after tumultuous year on campus
Australia wants businesses to diversify after China scraps wine tariffs
Japan drugmaker reports two more deaths in supplement scare
Chanel flap bag now costs more than 10,000 euros in Paris
Florida governor, Disney reach settlement in lawsuit over special district
Kobayashi Pharma ordered to recall red yeast rice pills after 2 deaths